A Retrospective Study of COVID-19 Treatments

ProgenaBiome300 enrolled

Overview

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Covid19 COVID-19 Pneumonia COVID-19 Respiratory Infection COVID-19 Acute Bronchitis COVID-19 Acute Respiratory Distress Syndrome COVID-19 Lower Respiratory Infection SARS-CoV2 Infection SARS-CoV-2 Acute Respiratory Disease

Interventions

No Intervention UsedOTHER

There is no intervention in this study

Eligibility

Sex: ALLMin age: 18 Months

Medical Language ↔ Plain English

Inclusion Criteria: 1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study 2. Male or female of 18 years of age or older 3. Diagnosis of COVID-19 infection by RT- PCR 4. Recovery from COVID-19 Exclusion Criteria:

Locations (1)

Ginger Aurella

Ventura, California, United States

Outcomes

Primary Outcomes

Survey Response

Answers given by subjects on their recovery from COVID-19

Time frame: One hour

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.